Detailed price information for Gain Therapeutics Inc (GANX-Q) from The Globe and Mail including charting and trades.

I hope the new FDA, which is the old FDA with newer understanding of President Trump’s expectations, will reembrace that spirit of right to try and the taking of a machete to the red tape that must be ...

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Capricor Therapeutics, Inc. (NASDAQ: CAPR) between October 9, 2024 and July 10, 2025, both dates inclusive ...

Reports Q4 revenue $16.94B, consensus $16.86B. Total case volume increased 11.9%. “Our organization finished fiscal 2025 with ...

Sees Q1 adjusted EBITDA $465M-$485M. The company said, “For the first quarter of fiscal 2026, PFG expects net sales to be in a range of approximately $16.6 billion to $16.9 billion. For the first ...